Catania C - Search Results

1

Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era.

Catania C, Piperno G, Russo A, Greco C, Agustoni F, Scotti V, Proto C, Sangalli C, Patani F, Santacaterina A, Di Pietro Paolo M, Agresti B, Filippi AR, Ramella S. Catania C, et al. Crit Rev Oncol Hematol. 2022 Jun;174:103684. doi: 10.1016/j.critrevonc.2022.103684. Epub 2022 Apr 21. Crit Rev Oncol Hematol. 2022. PMID: 35462031 Review.

2

Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.

De Pas T, Giovannini M, Rescigno M, Catania C, Toffalorio F, Spitaleri G, Delmonte A, Barberis M, Spaggiari L, Solli P, Veronesi G, De Braud F. De Pas T, et al. Among authors: catania c. Crit Rev Oncol Hematol. 2012 Sep;83(3):432-43. doi: 10.1016/j.critrevonc.2011.12.005. Epub 2012 Feb 25. Crit Rev Oncol Hematol. 2012. PMID: 22366114 Review.

3

Breast phyllodes tumor: a review of literature and a single center retrospective series analysis.

Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, Sangalli C, Catania C, Toffalorio F, Noberasco C, Delmonte A, Luini A, Veronesi P, Colleoni M, Viale G, Zurrida S, Goldhirsch A, Veronesi U, De Pas T. Spitaleri G, et al. Among authors: catania c. Crit Rev Oncol Hematol. 2013 Nov;88(2):427-36. doi: 10.1016/j.critrevonc.2013.06.005. Epub 2013 Jul 17. Crit Rev Oncol Hematol. 2013. PMID: 23871531 Free article. Review.

4

Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic options.

Lazzari C, Spitaleri G, Catania C, Barberis M, Noberasco C, Santarpia M, Delmonte A, Toffalorio F, Conforti F, De Pas TM. Lazzari C, et al. Among authors: catania c. Crit Rev Oncol Hematol. 2014 Mar;89(3):358-65. doi: 10.1016/j.critrevonc.2013.09.003. Epub 2013 Sep 26. Crit Rev Oncol Hematol. 2014. PMID: 24156959 Review.

5

Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumors.

Toffalorio F, de Marinis F, Conforti F, Spitaleri G, Catania C, Noberasco C, Lazzari C, Vecchio F, Stufano V, Barberis M, De Pas T. Toffalorio F, et al. Among authors: catania c. J Thorac Oncol. 2015 Feb;10(2):392-6. doi: 10.1097/JTO.0000000000000355. J Thorac Oncol. 2015. PMID: 25611230 Free article.

6

Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment.

Passaro A, Guerini-Rocco E, Pochesci A, Vacirca D, Spitaleri G, Catania CM, Rappa A, Barberis M, de Marinis F. Passaro A, et al. Pharmacol Res. 2017 Mar;117:406-415. doi: 10.1016/j.phrs.2017.01.003. Epub 2017 Jan 12. Pharmacol Res. 2017. PMID: 28089942 Review.

7

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.

Passaro A, Mancuso P, Gandini S, Spitaleri G, Labanca V, Guerini-Rocco E, Barberis M, Catania C, Del Signore E, de Marinis F, Bertolini F. Passaro A, et al. Among authors: catania c. Clin Transl Oncol. 2020 Apr;22(4):603-611. doi: 10.1007/s12094-019-02166-z. Epub 2019 Jun 28. Clin Transl Oncol. 2020. PMID: 31254252

8

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data.

Passaro A, Attili I, Morganti S, Del Signore E, Gianoncelli L, Spitaleri G, Stati V, Catania C, Curigliano G, de Marinis F. Passaro A, et al. Among authors: catania c. Cancer Treat Rev. 2020 Sep;89:102085. doi: 10.1016/j.ctrv.2020.102085. Epub 2020 Jul 22. Cancer Treat Rev. 2020. PMID: 32771858 Review.

9

The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.

Catania C, Muthusamy B, Spitaleri G, Del Signore E, Pennell NA. Catania C, et al. Clin Lung Cancer. 2022 Mar;23(2):108-115. doi: 10.1016/j.cllc.2021.11.003. Epub 2021 Nov 11. Clin Lung Cancer. 2022. PMID: 34952792 Review.

10

New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group.

Catania C, Filippi AR, Sangalli C, Piperno G, Russano M, Greco C, Scotti V, Proto C, Bennati C, Di Pietro Paolo M, Platania A, Olmetto E, Agustoni F, Teodorani N, Agbaje V, Russo A. Catania C, et al. Crit Rev Oncol Hematol. 2023 Oct;190:104108. doi: 10.1016/j.critrevonc.2023.104108. Epub 2023 Aug 24. Crit Rev Oncol Hematol. 2023. PMID: 37633350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page